These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39173683)

  • 21.
    Li Y; Qin J; Wu H; Xu Y; Zhang L; Su K; Cui Y; Wang H
    Pharm Biol; 2020 Dec; 58(1):695-700. PubMed ID: 32673137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes.
    Qi XY; Liang SC; Ge GB; Liu Y; Dong PP; Zhang JW; Wang AX; Hou J; Zhu LL; Yang L; Tu CX
    Food Chem Toxicol; 2013 Jun; 56():392-7. PubMed ID: 23500771
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Zhang N; Liu J; Chen Z; Dou W
    Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
    [No Abstract]   [Full Text] [Related]  

  • 24. Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6.
    Song M; Hong M; Lee MY; Jee JG; Lee YM; Bae JS; Jeong TC; Lee S
    Food Chem Toxicol; 2013 Sep; 59():549-53. PubMed ID: 23835282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.
    Prakash C; Kamel A; Cui D; Whalen RD; Miceli JJ; Tweedie D
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):35S-42S. PubMed ID: 10771452
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Li M; Liu X; Wang Y; Ju X
    Xenobiotica; 2020 Oct; 50(10):1202-1207. PubMed ID: 32338127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P450 3A4-mediated interaction of diclofenac and quinidine.
    Ngui JS; Tang W; Stearns RA; Shou M; Miller RR; Zhang Y; Lin JH; Baillie TA
    Drug Metab Dispos; 2000 Sep; 28(9):1043-50. PubMed ID: 10950847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of sirolimus in the presence or absence of cyclosporine by genotyped human liver microsomes and recombinant cytochromes P450 3A4 and 3A5.
    Picard N; Djebli N; Sauvage FL; Marquet P
    Drug Metab Dispos; 2007 Mar; 35(3):350-5. PubMed ID: 17151193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro Inhibitory Effects of Cynaroside on Human Liver Cytochrome P450 Enzymes.
    Wang L; Ma X; Wang J; Li C
    Pharmacology; 2019; 104(5-6):296-302. PubMed ID: 31587003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use.
    Luethi D; Hoener MC; Krähenbühl S; Liechti ME; Duthaler U
    Biochem Pharmacol; 2019 Jun; 164():129-138. PubMed ID: 30981875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory Effect of Vonoprazan on the Metabolism of [
    Nishihara M
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):713-717. PubMed ID: 30993551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids.
    Kamble SH; Sharma A; King TI; Berthold EC; León F; Meyer PKL; Kanumuri SRR; McMahon LR; McCurdy CR; Avery BA
    Toxicol Lett; 2020 Feb; 319():148-154. PubMed ID: 31707106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro and in Vivo Inhibitory Effects of Glycyrrhetinic Acid in Mice and Human Cytochrome P450 3A4.
    Lv QL; Wang GH; Chen SH; Hu L; Zhang X; Ying G; Qin CZ; Zhou HH
    Int J Environ Res Public Health; 2015 Dec; 13(1):84. PubMed ID: 26712778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome P450 reaction phenotyping and inhibition and induction studies of pinostrobin in human liver microsomes and hepatocytes.
    Tan S; Dong Z; Zhang J; Efferth T; Fu Y; Hua X
    Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 28111763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice.
    He W; Wu JJ; Ning J; Hou J; Xin H; He YQ; Ge GB; Xu W
    Toxicol In Vitro; 2015 Oct; 29(7):1569-76. PubMed ID: 26100226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4.
    Brown HS; Galetin A; Hallifax D; Houston JB
    Clin Pharmacokinet; 2006; 45(10):1035-50. PubMed ID: 16984215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
    Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
    Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent inhibitory effect of alpha-viniferin on human cytochrome P450.
    Sim J; Jang HW; Song M; Kim JH; Lee SH; Lee S
    Food Chem Toxicol; 2014 Jul; 69():276-80. PubMed ID: 24769006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6.
    Yumibe N; Huie K; Chen KJ; Snow M; Clement RP; Cayen MN
    Biochem Pharmacol; 1996 Jan; 51(2):165-72. PubMed ID: 8615885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of cytochrome P450 by ethambutol in human liver microsomes.
    Lee SY; Jang H; Lee JY; Kwon KI; Oh SJ; Kim SK
    Toxicol Lett; 2014 Aug; 229(1):33-40. PubMed ID: 24910189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.